Search research articles
Contact Us
Filters
Showing results (211-220 of 248) with videos related to
Page
of 25
Sort By:
BMC Cancer
|
June 2, 2016
ICECREAM: randomised phase II study of cetuximab alone or in combination with irinotecan in patients with metastatic colorectal cancer with either KRAS, NRAS, BRAF and PI3KCA wild type, or G13D mutated tumours
Eva Segelov, Paul Waring, Jayesh Desai, et al.
European Journal of Cancer (Oxford, England : 1990)
|
July 22, 2021
Prognostic nomogram for progression-free survival in patients with BRCA mutations and platinum-sensitive recurrent ovarian cancer on maintenance olaparib therapy following response to chemotherapy
Angelina Tjokrowidjaja, Michael Friedlander, Sarah J Lord, et al.
Gynecologic Oncology
|
March 25, 2021
Complete pathological response following levonorgestrel intrauterine device in clinically stage 1 endometrial adenocarcinoma: Results of a randomized clinical trial
Monika Janda, Kristy P Robledo, Val Gebski, et al.
International Journal of Radiation Oncology, Biology, Physics
|
April 3, 2020
Real-Time Image Guided Ablative Prostate Cancer Radiation Therapy: Results From the TROG 15.01 SPARK Trial
Paul Keall, Doan Trang Nguyen, Ricky O'Brien, et al.
Gynecologic Oncology
|
May 31, 2021
Corrigendum to "Complete pathological response following levonorgestrel intrauterine device in clinically stage 1 endometrial adenocarcinoma: Results of a randomized clinical trial" [Gynecologic Oncology 161 (2021) 143-151]
Monika Janda, Kristy P Robledo, Val Gebski, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
March 20, 2026
Adverse event profile following maintenance olaparib in patients with BRCA-mutated platinum-sensitive relapsed serous ovarian cancer in the phase III SOLO2 trial
Jonathan A Ledermann, Alain Lortholary, Richard T Penson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 26, 2011
Capecitabine versus classical cyclophosphamide, methotrexate, and fluorouracil as first-line chemotherapy for advanced breast cancer
Martin R Stockler, Vernon J Harvey, Prudence A Francis, et al.
British Journal of Cancer
|
December 21, 2025
High-dose vitamin D supplementation and prostate cancer progression: a phase II randomised trial in localised prostate cancer cases with intermediate risk of progression (ProsD)
Visalini Nair-Shalliker, David P Smith, Val Gebski, et al.
Respiratory Research
|
December 5, 2025
A randomised clinical trial of a digital self-management package for people with interstitial lung disease: the REBUILD-SM protocol
Carly Barton, Mariana Hoffman, Narelle S Cox, et al.
European Journal of Cancer (Oxford, England : 1990)
|
May 16, 2026
[<sup>177</sup>Lu]Lu-DOTATATE PRRT and CAPTEM chemotherapy for pancreas and small bowel neuroendocrine tumours: The AGITG CONTROL NETS Multi-centre randomized trial
David L Chan, Katrin Marie Sjoquist, David Turner Ransom, et al.
Page
of 25
Search research articles
Search
Showing results (211-220 of 248) with videos related to
Sort By:
Page
of 25
BMC Cancer
|
June 2, 2016
ICECREAM: randomised phase II study of cetuximab alone or in combination with irinotecan in patients with metastatic colorectal cancer with either KRAS, NRAS, BRAF and PI3KCA wild type, or G13D mutated tumours
Eva Segelov, Paul Waring, Jayesh Desai, et al.
European Journal of Cancer (Oxford, England : 1990)
|
July 22, 2021
Prognostic nomogram for progression-free survival in patients with BRCA mutations and platinum-sensitive recurrent ovarian cancer on maintenance olaparib therapy following response to chemotherapy
Angelina Tjokrowidjaja, Michael Friedlander, Sarah J Lord, et al.
Gynecologic Oncology
|
March 25, 2021
Complete pathological response following levonorgestrel intrauterine device in clinically stage 1 endometrial adenocarcinoma: Results of a randomized clinical trial
Monika Janda, Kristy P Robledo, Val Gebski, et al.
International Journal of Radiation Oncology, Biology, Physics
|
April 3, 2020
Real-Time Image Guided Ablative Prostate Cancer Radiation Therapy: Results From the TROG 15.01 SPARK Trial
Paul Keall, Doan Trang Nguyen, Ricky O'Brien, et al.
Gynecologic Oncology
|
May 31, 2021
Corrigendum to "Complete pathological response following levonorgestrel intrauterine device in clinically stage 1 endometrial adenocarcinoma: Results of a randomized clinical trial" [Gynecologic Oncology 161 (2021) 143-151]
Monika Janda, Kristy P Robledo, Val Gebski, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
March 20, 2026
Adverse event profile following maintenance olaparib in patients with BRCA-mutated platinum-sensitive relapsed serous ovarian cancer in the phase III SOLO2 trial
Jonathan A Ledermann, Alain Lortholary, Richard T Penson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 26, 2011
Capecitabine versus classical cyclophosphamide, methotrexate, and fluorouracil as first-line chemotherapy for advanced breast cancer
Martin R Stockler, Vernon J Harvey, Prudence A Francis, et al.
British Journal of Cancer
|
December 21, 2025
High-dose vitamin D supplementation and prostate cancer progression: a phase II randomised trial in localised prostate cancer cases with intermediate risk of progression (ProsD)
Visalini Nair-Shalliker, David P Smith, Val Gebski, et al.
Respiratory Research
|
December 5, 2025
A randomised clinical trial of a digital self-management package for people with interstitial lung disease: the REBUILD-SM protocol
Carly Barton, Mariana Hoffman, Narelle S Cox, et al.
European Journal of Cancer (Oxford, England : 1990)
|
May 16, 2026
[<sup>177</sup>Lu]Lu-DOTATATE PRRT and CAPTEM chemotherapy for pancreas and small bowel neuroendocrine tumours: The AGITG CONTROL NETS Multi-centre randomized trial
David L Chan, Katrin Marie Sjoquist, David Turner Ransom, et al.
Page
of 25